Induction of hyporesponsiveness and prolongation of cardiac allograft survival after jejunal administration of donor splenocytes and its abrogation by administration of gadolinium.
Ishido
N
N
Department of Surgery, Kagawaken Saiseikai Hospital, Takamatsu, Japan.
Matsuoka
J
J
Matsuno
T
T
Nakagawa
K
K
Tanaka
N
N
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D005260:Female; D005682:Gadolinium / Q000494:pharmacology*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D007583:Jejunum; D017710:Lymphocyte Transfusion; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013154:Spleen / Q000276:immunology; D014184:Transplantation, Homologous
D000893:Anti-Inflammatory Agents; D005682:Gadolinium; C038958:gadolinium chloride